Similar articles

• Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.

  Monsma FJ Jr, Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA. Monsma FJ Jr, et al. Endocrinology. 1984 Jul;115(1):143-53. doi: 10.1210/endo-115-1-143. Endocrinology. 1984. PMID: 6734512
• Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.

  Elliston JF, Zablocki JA, Katzenellenbogen BS, Katzenellenbogen JA. Elliston JF, et al. Endocrinology. 1987 Aug;121(2):667-76. doi: 10.1210/endo-121-2-667. Endocrinology. 1987. PMID: 3595536
• Tamoxifen aziridines: effective inactivators of the estrogen receptor.

  Robertson DW, Wei LL, Hayes JR, Carlson KE, Katzenellenbogen JA, Katzenellenbogen BS. Robertson DW, et al. Endocrinology. 1981 Oct;109(4):1298-300. doi: 10.1210/endo-109-4-1298. Endocrinology. 1981. PMID: 7285873
• Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.

  Pavlik EJ, Nelson K, van Nagell JR Jr, Donaldson ES, Walden ML, Gallion H, Kenady DE. Pavlik EJ, et al. Endocrinology. 1987 Apr;120(4):1608-14. doi: 10.1210/endo-120-4-1608. Endocrinology. 1987. PMID: 3830064
• A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.

  Ratajczak T, Atrache V, Antes P, Comber M, Hähnel R. Ratajczak T, et al. Steroids. 1988 May-Jun;51(5-6):499-518. doi: 10.1016/0039-128x(88)90047-5. Steroids. 1988. PMID: 3242173